<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/ncpuro/current_issue/rss">
<title>Nature Clinical Practice Urology</title>
<description>Nature Clinical Practice Urology provides urologists with authoritative and timely interpretations of key developments in the field, translating the latest findings into clinical practice.</description>
<link>http://www.nature.com/ncpuro/current_issue/</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>&#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:issn>1743-4270</prism:issn>
<prism:eIssn>1743-4289</prism:eIssn>
<prism:copyright>&#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/ncpuro_logo.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1256"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1245"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1239"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1233"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1232"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1213"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1251"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1253"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpuro1229"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/ncpuro_logo.gif">
<title>Nature Clinical Practice Urology</title>
<url>http://www.nature.com/includes/rj_globnavimages/ncpuro_logo.gif</url>
<link>http://www.nature.com/ncpuro/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1256">
<title>Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?</title>
<link>http://dx.doi.org/10.1038/ncpuro1256</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1256">doi:10.1038/ncpuro1256</a>
</p>
<p>Authors: Christian Doehn
&amp; Dieter Jocham</p>
]]></content:encoded>
<dc:title>Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?</dc:title>
<dc:creator>Christian Doehn</dc:creator>
<dc:creator>Dieter Jocham</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1256</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-11-11</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Practice Point</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1245">
<title>Does antibiotic prophylaxis prevent renal scarring in children with vesicoureteral reflux?</title>
<link>http://dx.doi.org/10.1038/ncpuro1245</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Does antibiotic prophylaxis prevent renal scarring in children with vesicoureteral reflux?</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1245">doi:10.1038/ncpuro1245</a>
</p>
<p>Author: Jack S Elder</p>
]]></content:encoded>
<dc:title>Does antibiotic prophylaxis prevent renal scarring in children with vesicoureteral reflux?</dc:title>
<dc:creator>Jack S Elder</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1245</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-10-28</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-10-28</prism:publicationDate>
<prism:section>Practice Point</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1239">
<title>Is radiofrequency ablation more cost-effective than nephron-sparing surgery for small unilateral renal cell carcinoma?</title>
<link>http://dx.doi.org/10.1038/ncpuro1239</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Is radiofrequency ablation more cost-effective than nephron-sparing surgery for small unilateral renal cell carcinoma?</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1239">doi:10.1038/ncpuro1239</a>
</p>
<p>Authors: Robert J Stein
&amp; Inderbir S Gill</p>
]]></content:encoded>
<dc:title>Is radiofrequency ablation more cost-effective than nephron-sparing surgery for small unilateral renal cell carcinoma?</dc:title>
<dc:creator>Robert J Stein</dc:creator>
<dc:creator>Inderbir S Gill</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1239</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-10-28</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-10-28</prism:publicationDate>
<prism:section>Practice Point</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1233">
<title>Should patients with localized prostate cancer receive primary androgen deprivation therapy?</title>
<link>http://dx.doi.org/10.1038/ncpuro1233</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Should patients with localized prostate cancer receive primary androgen deprivation therapy?</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1233">doi:10.1038/ncpuro1233</a>
</p>
<p>Authors: Mikio Namiki, Atsushi Mizokami
&amp; Hideyuki Akaza</p>
]]></content:encoded>
<dc:title>Should patients with localized prostate cancer receive primary androgen deprivation therapy?</dc:title>
<dc:creator>Mikio Namiki</dc:creator>
<dc:creator>Atsushi Mizokami</dc:creator>
<dc:creator>Hideyuki Akaza</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1233</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-10-21</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-10-21</prism:publicationDate>
<prism:section>Practice Point</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1232">
<title>What is the current status of second-line chemotherapy for castration-resistant prostate cancer?</title>
<link>http://dx.doi.org/10.1038/ncpuro1232</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>What is the current status of second-line chemotherapy for castration-resistant prostate cancer?</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1232">doi:10.1038/ncpuro1232</a>
</p>
<p>Authors: Jonathan E Rosenberg
&amp; William K Oh</p>
]]></content:encoded>
<dc:title>What is the current status of second-line chemotherapy for castration-resistant prostate cancer?</dc:title>
<dc:creator>Jonathan E Rosenberg</dc:creator>
<dc:creator>William K Oh</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1232</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-10-21</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-10-21</prism:publicationDate>
<prism:section>Practice Point</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1213">
<title>Can imaging be used to assess treatment success after ablation of renal tumors?</title>
<link>http://dx.doi.org/10.1038/ncpuro1213</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Can imaging be used to assess treatment success after ablation of renal tumors?</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1213">doi:10.1038/ncpuro1213</a>
</p>
<p>Author: Stephen B Solomon</p>
]]></content:encoded>
<dc:title>Can imaging be used to assess treatment success after ablation of renal tumors?</dc:title>
<dc:creator>Stephen B Solomon</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1213</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-09-16</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-09-16</prism:publicationDate>
<prism:section>Practice Point</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1251">
<title>Sacral neuromodulation for urinary retention</title>
<link>http://dx.doi.org/10.1038/ncpuro1251</link>
<description>Sacral neuromodulation (SNM) has been investigated as a treatment for a range of refractory lower urinary tract disorders. In this Review, Kessler and Fowler discuss developments in SNM techniques and technology, assess patient outcomes, and consider potential mechanisms of action for this therapy.</description>
<content:encoded><![CDATA[

<p>
<b>Sacral neuromodulation for urinary retention</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1251">doi:10.1038/ncpuro1251</a>
</p>
<p>Authors: Thomas M Kessler
&amp; Clare J Fowler</p>
]]></content:encoded>
<dc:title>Sacral neuromodulation for urinary retention</dc:title>
<dc:creator>Thomas M Kessler</dc:creator>
<dc:creator>Clare J Fowler</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1251</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-11-11</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Review</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1253">
<title>Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder</title>
<link>http://dx.doi.org/10.1038/ncpuro1253</link>
<description>This Case Study describes a 60-year-old woman who presented with an enlarging subcutaneous lesion on her right flank, 6 months after having undergone treatment for transitional cell carcinoma (TCC) of the bladder. The article highlights that rare cutaneous TCC metastases can mimic common benign and inflammatory processes, and the authors suggest treatment options for such patients.</description>
<content:encoded><![CDATA[

<p>
<b>Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1253">doi:10.1038/ncpuro1253</a>
</p>
<p>Authors: Hannah H Alphs, Jennifer Miles-Thomas, Frank Attenello, Janis M Taube, Gustavo Fonseca, Thomas J Guzzo, Mark P Schoenberg
&amp; Trinity J Bivalacqua</p>
]]></content:encoded>
<dc:title>Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder</dc:title>
<dc:creator>Hannah H Alphs</dc:creator>
<dc:creator>Jennifer Miles-Thomas</dc:creator>
<dc:creator>Frank Attenello</dc:creator>
<dc:creator>Janis M Taube</dc:creator>
<dc:creator>Gustavo Fonseca</dc:creator>
<dc:creator>Thomas J Guzzo</dc:creator>
<dc:creator>Mark P Schoenberg</dc:creator>
<dc:creator>Trinity J Bivalacqua</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1253</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-11-11</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-11-11</prism:publicationDate>
<prism:section>Case Study</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpuro1229">
<title>A case of staghorn stones in a kidney with an ileal ureter treated by percutaneous nephrolithotomy</title>
<link>http://dx.doi.org/10.1038/ncpuro1229</link>
<description>In this Case Study, Gao  et al. present a 59-year-old man with complete staghorn calculi who had previously undergone ileal ureteral replacement. The patient was successfully treated with percutaneous nephrolithotomy. The authors emphasize the essential role of CT urography in diagnosis and treatment planning in such complex cases.</description>
<content:encoded><![CDATA[

<p>
<b>A case of staghorn stones in a kidney with an ileal ureter treated by percutaneous nephrolithotomy</b>
</p>
<p>Nature Clinical Practice Urology. <a href="http://dx.doi.org/10.1038/ncpuro1229">doi:10.1038/ncpuro1229</a>
</p>
<p>Authors: Xiaofeng Gao, Tie Zhou, Jinyi Li
&amp; Yinghao Sun</p>
]]></content:encoded>
<dc:title>A case of staghorn stones in a kidney with an ileal ureter treated by percutaneous nephrolithotomy</dc:title>
<dc:creator>Xiaofeng Gao</dc:creator>
<dc:creator>Tie Zhou</dc:creator>
<dc:creator>Jinyi Li</dc:creator>
<dc:creator>Yinghao Sun</dc:creator>
<dc:identifier>doi:10.1038/ncpuro1229</dc:identifier>
<dc:source>Nature Clinical Practice Urology</dc:source>
<dc:date>2008-10-07</dc:date>
<prism:publicationName>Nature Clinical Practice Urology</prism:publicationName>
<prism:publicationDate>2008-10-07</prism:publicationDate>
<prism:section>Case Study</prism:section>
<prism:startingPage/>
<prism:endingPage/>
</item>
</rdf:RDF>
